Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;26(6):521-37.
doi: 10.1521/aeap.2014.26.6.521.

Adherence to antiretroviral therapy among HIV-infected adults in the United States

Linda Beer, Jacek Skarbinski

Adherence to antiretroviral therapy among HIV-infected adults in the United States

Linda Beer et al. AIDS Educ Prev. 2014 Dec.

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] AIDS Educ Prev. 2015 Oct;27(5):489-91. doi: 10.1521/aeap.2015.27.5.489. AIDS Educ Prev. 2015. PMID: 26485237 No abstract available.

Abstract

National estimates of antiretroviral therapy (ART) adherence and adherence support services utilization are needed to inform efforts to improve the health of HIV-infected persons in the United States. In a nationally representative sample of HIV-infected adults receiving medical care, 86% self-reported taking all ART doses in the past 72 hours. Overall, 20% reported using adherence support services and 2% reported an unmet need for services. If all nonadherent persons not receiving adherence support and all persons with a self-perceived unmet need for adherence support accessed services, resources to support ∼42,673 additional persons would be needed. Factors associated with lower adherence included younger age, female gender, depression, stimulant use, binge alcohol use, greater than once-daily dosing, longer time since HIV diagnosis, and patient beliefs. Predictors of adherence are multifactorial so multiple targeted strategies to improve adherence are warranted. Providing adherence support services to all those in need may require additional resources.

PubMed Disclaimer

References

    1. Aldir I, Horta A, Serrado M. Single-tablet regimens in HIV: Does it really make a difference? Current Medical Research and Opinion. 2013;30(1):89–97. doi:10.1185/03007995.2013.844685. - PubMed
    1. Amico KR, Orrell C. Antiretroviral therapy adherence support: Recommendations and future directions. Journal of the International Association of Providers of AIDS Care. 2013;12(2):128–137. doi:10.1177/1545109712459041. - PubMed
    1. Amico KR, Zuniga JM, Wilson IB, Gross R, Young B. Provider guidance for linking patients to antiretroviral therapy adherence interventions: Recommendations from an IAPAC Advisory Committee on Adherence Monitoring and Support. Journal of the International Association of Providers of AIDS Care. 2013;12(2):79–83. doi:10.1177/1545109712474844. - PubMed
    1. Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status. Health Psychology. 2007;26(1):40–49. doi:10.1037/0278-6133.26.1.40. - PMC - PubMed
    1. Binford MC, Kahana SY, Altice FL. A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Current HIV/ AIDS Reports. 2012;9:287–312. doi:10.1007/s11904-012-0134-8. - PMC - PubMed

Publication types

Substances